Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: A second tumorigenic event? [9]

Leukemia

Volumn 20, Issue 3, 2006, Pages 530-534

  McCann, K J ^a   Johnson, P W M ^a   Stevenson, F K ^a   Ottensmeier, C H ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; SERINE; THREONINE; TYROSINE;

AMINO ACID SUBSTITUTION; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CODON USAGE; CONTROLLED STUDY; CYTOPATHOLOGY; FOLLICULAR LYMPHOMA; GENE SEQUENCE; GLYCOSYLATION; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; LETTER; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PURIFICATION; SEQUENCE ANALYSIS; SOMATIC MUTATION;

EID: 33644501823     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404095     Document Type: Letter

References (11)

1. Zhu D, McCarthy H, Ottensmeier CH, Johnson P, Hamblin TJ, Stevenson FK. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 2002; 99: 2562-2568.
2. Zhu D, Ottensmeier CH, Du MQ, McCarthy H, Stevenson FK. Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma. Br J Haematol 2003; 120: 217-222.
3. Bahler DW, Campbell MJ, Hart S, Miller RA, Levy S, Levy R. Ig VH gene expression among human follicular lymphomas. Blood 1991; 78: 1561-1568.
4. Hsu FJ, Levy R. Preferential use of the VH4 Ig gene family by diffuse large-cell lymphoma. Blood 1995; 86: 3072-3082.
5. Stamatopoulos K, Kosmas C, Papadaki T, Pouliou E, Belessi C, Afendaki S et al. Follicular lymphoma immunoglobulin kappa light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains. Br J Haematol 1997; 96: 132-146.
6. Noppe SM, Heirman C, Bakkus MH, Brissinck J, Schots R, Thielemans K. The genetic variability of the VH genes in follicular lymphoma: The impact of the hypermutation mechanism. Br J Haematol 1999; 107: 625-640.
7. Aarts WM, Bende RJ, Steenbergen EJ, Kluin PM, Ooms EC, Pals ST et al. Variable heavy chain gene analysis of follicular lymphomas: Correlation between heavy chain isotype expression and somatic mutation load. Blood 2000; 95: 2922-2929.
8. Zabalegui N, de Cerio AL, Inoges S, Rodriguez-Calvillo M, Perez-Calvo J, Hernandez M et al. Acquired potential N-glycosylation sites within the tumor-specific immunoglobulin heavy chains of B-cell malignancies. Haematologica 2004; 89: 541-546.
9. Kasturi L, Chen H, Shakin-Eshleman SH. Regulation of N-linked core glycosylation: Use of a site-directed mutagenesis approach to identify Asn-Xaa-Ser/Thr sequons that are poor oligosaccharide acceptors. Biochem J 1997; 323 (Part 2): 415-419.
10. Dorner T, Brezinschek HP, Brezinschek RI, Foster SJ, Domiati-Saad R, Lipsky PE. Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J Immunol 1997; 158: 2779-2789.
11. Foster SJ, Dorner T, Lipsky PE. Targeting and subsequent selection of somatic hypermutations in the human V kappa repertoire. Eur J Immunol 1999; 29: 3122-3132.